Prematurity and intrauterine growth retardation--double jeopardy?

Rivka H Regev1, Brian Reichman

  • 1Neonatal Unit and Neonatal Follow-Up Clinic, Neonatal Department, Meir Hospital, Sapir Medical Center, Kfar Saba 44281, Israel. regevdr@netvision.net.il

Clinics in Perinatology
|August 25, 2004
PubMed

Insights

Infants born small for gestational age (SGA) with intrauterine growth restriction (IUGR) face higher risks of death and serious health issues. IUGR may also program later-life diseases like cardiovascular conditions and diabetes.

Area of Science:

  • Neonatalogy
  • Perinatology
  • Developmental Pediatrics

Background:

  • Intrauterine growth restriction (IUGR) significantly increases mortality and major neonatal morbidities in premature infants.
  • These complications, including respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), retinopathy of prematurity (ROP), and necrotizing enterocolitis (NEC), are exacerbated by suboptimal fetal growth.
  • Emerging evidence links IUGR to the later development of adult-onset cardiovascular diseases, hypertension, and diabetes mellitus.

Purpose of the Study:

  • To discuss the pathophysiologic processes underlying IUGR and its consequences.
  • To highlight the role of IUGR as a risk factor for long-term health problems.
  • To emphasize the need for experimental research into IUGR's etiology and pathophysiology.

Main Methods:

  • Review of pathophysiologic processes initiated in utero and continuing postnatally.
  • Analysis of recently reported data on IUGR and long-term health outcomes.
  • Discussion of experimental research directions.

Main Results:

  • Premature infants with IUGR exhibit a substantially increased risk of mortality and severe neonatal morbidities.
  • Suboptimal fetal growth intensifies the severity of prematurity-related complications.
  • IUGR is identified as a programming risk factor for adult cardiovascular diseases, hypertension, and diabetes.

Conclusions:

  • Understanding the pathophysiology of IUGR is crucial for addressing neonatal complications.
  • Interventions targeting IUGR may reduce both short-term and long-term mortality and morbidity in small for gestational age (SGA) infants.
  • Further experimental research is essential to develop effective strategies for mitigating the risks associated with IUGR.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...